LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 107 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $367,400 | -52.0% | 337,064 | +0.8% | 0.00% | -50.0% |
| Q2 2023 | $765,435 | +51.2% | 334,251 | +60.4% | 0.00% | +33.3% |
| Q1 2023 | $506,249 | +97.0% | 208,333 | +54.8% | 0.00% | +200.0% |
| Q4 2022 | $257,004 | +55.8% | 134,557 | +178.9% | 0.00% | 0.0% |
| Q4 2020 | $165,000 | +3.8% | 48,249 | -56.2% | 0.00% | 0.0% |
| Q3 2020 | $159,000 | +12.8% | 110,263 | +55.5% | 0.00% | 0.0% |
| Q2 2020 | $141,000 | +65.9% | 70,911 | +62.3% | 0.00% | 0.0% |
| Q1 2020 | $85,000 | -78.8% | 43,700 | +7.7% | 0.00% | -50.0% |
| Q4 2017 | $401,000 | +158.7% | 40,575 | +222.7% | 0.00% | +100.0% |
| Q3 2017 | $155,000 | – | 12,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |